Galapagos will begin a phase II trial of the drug with 180 patients in 2014. The companies hope the drug will quickly move to a phase III trial.
More Articles on Gastroenterology:
8 Trends Shaping the Present & Future of Gastroenterology
Dr. Andrew Rhim Receives AGA Digestive Cancer Award, $40k Grant
Boston Scientific to Present Data at Digestive Disease Week
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
